Geography, generalisability, and susceptibility in clinical trials

Abstract
Description
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Clougherty, J. E., Kinnee, E. J., Cardet, J. C., Mauger, D., Bacharier, L., Beigelman, A., ... & Holguin, F. (2021). Geography, generalisability, and susceptibility in clinical trials. The Lancet Respiratory Medicine, 9(4), 330-332. https://doi.org/10.1016/S2213-2600(21)00046-1
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
The Lancet Respiratory Medicine
Rights
Public Health Emergency
Source
Publisher
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}